We are international
Donate
• webcasts   TEXT SIZE   

51st Annual ASH Meeting

The IMF brings you highlights from the 51st annual meeting of the American Society of Hematology. We interviewed over 50 of the myeloma experts at the meeting, covering over 80 of the presentations being made about myeloma.

get adobe flash player These videos are now up on the web, along with the presentation abstracts and slides where available. If you have any issues with the videos not playing properly, please upgrade your Adobe Flash Player.This is free software provided by Adobe Systems.

Overviews
International
Ask The Experts
Revlimid
Thalomid
Velcade
New Agents
Transplant
Newly Diagnosed
Relapsed/Refractory
Bank On A Cure
Others
ASH 2009: Dr. Brian Durie, Cedars Sinai Comprehensive Cancer Center, Los Angeles, California
"For the first time, we are seeing the role of the novel agents across the whole spectrum of myeloma" View
ASH 2009: Paul Richardson, Dana Farber Cancer Institute, Boston, Massachusetts
Paul Richardson, MD
Dana Farber Cancer Institute
Boston, Massachusetts View

ASH 2009: Sundar Jagannath, Overview
Sundar Jagannath, MD
St. Vincents Comprehensive Cancer Center
New York, NY View
Dr. Morie Gertz, Mayo Clinic, Rochester, Minnesota
"This has been the most exciting and promising American Society of Hematology meeting in the last ten years" View

Dr. Vincent Rajkumar, Mayo Clinic, Rochester, Minnesota
"There are many important presentations at this ASH meeting" View
Update from ASH 2009:
Novel Agents
"Today we reported on three drugs that will be part of future treatment choices for myeloma patients." View